Immunome
$7.73
11
+$0.03+0.39% Friday 21:00
Statistics
Day High
7.87
Day Low
7.54
52W High
9.53
52W Low
2.2
Volume
97,215
Avg. Volume
102,008
Mkt Cap
330.3M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Upcoming
Earnings
14MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
-0.76
-0.31
0.13
0.58
Expected EPS
-0.12
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IMNM. It's not an investment recommendation.
About
Health Technology
Biotechnology
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Show more...
CEO
Employees
39
Country
US
ISIN
US45257U1088